$18.60
+0 (+0%)
At Close: May 12, 2022
ImmunoPrecise Antibodies and Mila Announce Strategic AI Partnership
07:30am, Tuesday, 03'rd Nov 2020
VICTORIA, BC, Nov. 3, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), a leader in full-service, therapeutic antibody discovery and de
Sign In
Buy IPATF